For clinical features, the proportion of patients with AST or ALT>ULN and the median duration of disease in the PBC plus hypertension group were lower than those in the non-hypertension group (71.2% vs. 82.7%, P=0.003; 81.5 months vs. 94 months, P=0.023). The gene discussed is GPT; the disease is hypertensive disorder.